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ABSTRACT 
 
 
 The purpose of this project was to determine whether the Coxsackievirus B 
(CVB) uses toll-like receptors (TLR) to enter cells.  In the signal transduction pathway of 
Toll-like Receptors,  phosphorylation of the inhibitor protein IκB (by either of the IκB 
kinases (IKK)1 or IKK2) leads to the degradation of IκB.  IκB is always associated with 
NF-κB, which is a transcription signaling molecule.  When IκB is degraded, NF-κB is 
translocated into the nucleus, and ultimately causes cytokines, especially interleukin-8 
(IL-8) to be synthesized and released.  This project involved the creation of a DNA 
reporter plasmid that in the presence of free cellular NF-κB expresses the reporter protein 
dsRed-Express-1.  This NF-κB reporter plasmid was transiently transfected into several 
different Human Embryonic Kidney (HEK 293) cell lines which were each stably 
transfected with different TLRs.  Known ligands for these TLRs were used to test the 
specificity of the expression of the fluorescent signal.  Once the system was shown to 
work well with positive control ligands, Coxsackievirus was used as a ligand, and it was 
shown that Coxsackievirus does indeed activate NF-κB, but not by the classic pathway, 
no IL8 synthesis was detected.  So CVB does not appear to interact with any of the TLRs 
used in this specific HEK cell line, but it does not fully rule out an interaction between 
TLRs and CVB in other cells. 
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BACKGROUND 
  
 Immunology is considered to be a relatively new science.  Most scientists 
contribute its origin to Edward Jenner, who in 1796 discovered that cowpox, or vaccinia, 
induced protection against human smallpox, hence the term vaccination which we still 
use today.  Robert Koch then proved, in the late 19th century, that infectious diseases are 
caused by microorganisms, and each one is responsible for a different pathology. Today 
we recognize four different classes of disease-causing microorganisms, or pathogens: 
viruses, bacteria, fungi, and parasites.  In the 1880s, Louis Pasteur devised a vaccine 
against cholera in chickens, and a vaccine against rabies.  These practical advances 
sparked searches into the mechanism of protection that these vaccines provided, and thus 
the development of the science of immunology (Janeway et al 2001). 
 
 Toll-like Receptors 
 The Toll receptor was originally found in Drosophilia and was determined to be 
essential in the determination of the dorso-ventral pattern in embryo development, it was 
also determined that Toll-mutant flies were highly susceptible to fungal infection 
(Hashimoto et al 1988; Lemaitre et al 1996).  These studies showed how the innate 
immune system has the ability to specifically recognize invading microorganisms, and 
since then mammalian homologues have been found and subsequently names Toll-like 
receptors (TLR) (Takeda 2005).  The TLR family contains at least 11 members (TLR1–
TLR11) (Takeda 2005). The cytoplasmic portion of Toll-like receptors is very similar to 
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The cytoplasmic portion of the IL-1 receptor family, and is therefore referred to as the 
Toll/IL-1 receptor (TIR) domain (Takeda 2005). Despite this cytoplasmic similarity, the 
extracellular portions are not conserved between the two types of receptors.  “IL-1 
receptors possess an Ig-like domain, whereas Toll-like receptors bear leucine-rich repeats 
(LRRs) in the extracellular domain (Takeda 2005).” The physiological functions of TLRs 
have mostly been determined by the analysis of knockout mice. Each TLR recognizes 
specific portions of micro-organisms that are conserved (Takeda et al 2003). Thus, the 
mammalian innate immune system can detect invasion by pathogens via the recognition 
of microbial  components by TLRs (Janeway and Medzhitov 2002). 
 
 TLR Signaling Pathway 
 The TLR signaling pathways begins in the TIR domains. This was first revealed 
in the C3H/HeJ mouse strain, which contains a point mutation of a proline residue in the 
TIR domain of TLR4 (Poltorak et al 1998; Hoshino et al 1999).  “In the signaling 
pathways downstream of the TIR domains, an important role for a TIR domain-
containing adaptor, MyD88, was first characterized. MyD88 possesses a TIR domain in 
its C-terminal portion, and a death domain in its Nterminal portion. Upon stimulation, 
MyD88 recruits a serine/ threonine kinase, IL-1 receptor-associated kinase (IRAK), to 
TLRs through interaction of the death domains of both molecules. IRAK becomes 
activated and then associates with TRAF6, leading to NF-κB activation (Takeda 2005).”  
Therefore, the signaling protein MyD88 is required for cytokine activation as shown in 
Figure 1 (Takeda 2005).     
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 In TLR3 and TLR4 pathways, NF-κB activation can also occur via a TRIF 
pathway that is independent of MyD88 shown in figure 2 (Takeda 2005). 
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NF-κB Activation 
 There are two pathways by which NF-κB is activated.  The classical pathway 
which is based on IKKb-dependent IkB degradation, is essential for innate immunity 
(Bonizzi and Karin 2004).  “The activation and nuclear translocation of classical NF-kB 
dimers is associated with increased transcription of genes encoding chemokines, 
cytokines, adhesion molecules [intercellular adhesion molecule 1 (ICAM-1), vascular cell 
adhesion molecule-1 (VCAM-1) and endothelial–leukocyte adhesion molecule 1 
(ELAM)], enzymes that produce secondary inflammatory mediators and inhibitors of 
apoptosis” (Ghosh et al 1998; Bonizzi and Karin 2004) as shown in Figure 3a.  These 
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proteins recruit inflammatory and phagocytic cells to the site of the infection (Bonizzi 
and Karin 2004).    
 Recently, there has been a second pathway that has begun to be described.  This 
pathway, dependant upon IKKα (Senftleben et al 2001) and independent upon IKKβ and 
IKKγ (Dejardin et al 2002) is shown in figure 3b (Bonizzi and Karin 2004).  In the 
alternative pathway, the signal transduction pathway does not originate from the TLRs 
(Bonizzi and Karin 2004).  Also shown in the figure, is the difference in the proteins 
produced based on the activation of NF-κB, the secondary pathway produces proteins 
that are necessary for adaptive immune responses, while the classical pathway produces 
proteins used in innate immune responses (Bonizzi and Karin 2004). 
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   Figure 3:  Classic and Alternative NF-κB Pathways. 
 
An important thing to notice is the production of the cytokine IL-8 through the classic 
pathway, and the non-production of IL-8 through the alternative pathway. 
 
Coxsakievirus B 
 Coxsakievirus B (CVB) is an enterovirus that is closely related to poliovirus.  
CVB is a much less of a health hazard then poliovirus is, however, it still remains a 
pathogen that is of concern (Asher and Finberg 2004).  In humans, a range of acute and 
chronic diseases are caused by CVB (Brown and O’Connell 1996).  The gastrointestinal 
(GI) tract is a major site of CVB replication, however, symptoms induced by CVB in the 
GI are not usually seen (Flint 2004).  CVB is a picornavirus, a family of viruses that is 
the leading cause of aseptic meningitis in adults (Whitton 2002).  In infants, CVB is of 
particular concern, as it can cause life-threatening aseptic meningitis, myocarditis, and 
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fulminant hepatitis (Goren 1989, Gorwishankar 1914, Kaplan et al 1983; Kawashima et 
al 2004; Wang et al 1998).   
  One of the most surprising characteristics of CVB is that most adults have been 
infected at one time.  CVB is the leading cause of adult myocarditis (Kearny et al 2001).  
Studies show: 86% of the tested population had neutralizing antibodies against 2 
serotypes of CVB (Eggers and Mertens 1987).  Of those exposed, about half are expected 
to have an episode of acute viral mycocarditis (O’Connell 1987).  In a given population 
and at any given time point, around 1% of the population may be experiencing a 
subclinical episode (Gravanis and Sternby 1991).  Patients with myocarditis have mild 
symptoms such as rash, myalgia or upper respiratory or they are asymptomatic (Whitton 
2002).  In general, most infections caused by CVB are resolved naturally without any 
further complications; however, myocarditis can sometimes lead to death (Asher and 
Finberg 2004).  It has been found that asymptomatic myocarditis is a major cause of 
sudden, unexpected death in young persons (Drory et al 1991; Ward 1978).    
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PROJECT PURPOSE 
 
 The purpose of this project is to determine whether or not Coxsackievirus B 
(CVB) interacts with any of the Toll-like receptors (TLR).  Unpublished laboratory data 
suggests that mice infected with CVB show an up-regulation of TLR 4 in the heart and 
spleen compared to non-infected control mice.  This led the laboratory to believe that 
there may be some interaction between CVB and the TLRs.  To determine this, an in 
vitro reporter system was created that expresses a fluorescent signal upon NF-κB 
activation.  NF-κB is activated by two different pathways, one of which originates with 
an external signal in the TLRs, and the other is caused by cellular signaling.  To 
determine which pathway was used to activate NF-κB, an IL-8 ELISA was performed.  
Only the TLR pathway will cause the cytokine IL-8 to be released.  Therefore, we could 
better determine whether or not CVB is recognized by the TLRs. 
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METHODS 
 
Transformation of Competent E. coli Cells Using Heat Shock 
 Beginning with the two commercially available plasmids (pNF-κB-d2EGFP and 
pDsRed-Express-1) competent E. coli cells were transformed using a heat shock protocol.  
The E. coli cells transformed with pNF-κB-d2EGFP were grown up on agar trays 
containing ampicillin, and cells transformed with pDsRed-Express-1 were grown up on 
agar containing kanamycin. 
 
Cell Culture Medium 
 Medium used was Dubelco’s Modified Eagle’s Media (DMEM), supplemented 
with 10% fetal bovine serum (FBS), 1% l-glutamine, 1% penicillin, and 1% 
streptomycin.  Media were stored at 4°C. 
 
Mini-prep 
 Mini-preps were performed using the mini-prep kit (Qiagen) followed by 
restriction enzyme digestion and southern blot to determine if the plasmids had been 
transformed correctly.   
 
Maxi-prep 
 Once the plasmids had been determined to be correct, a maxi-prep done using the 
Maxi-prep kit (Qiagen) to isolate a large amount of plasmid DNA.   
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Ligation 
 To create the pNF-κB-DsRed-Express-1 plasmid, both of the commercially 
available plasmids were digested in SacI and HindIII.  Then the kappa enhancer element 
from pNF-κB-d2EGFP (KB4) and the TK promoter were ligated into the MCS of 
pDsRed-Express-1.  The ligations were performed by Dr. Neeta Shenoy. 
 
Sequencing 
 Plasmids were sent to the UMASS Medical School sequencing facility to verify 
the accuracy of the cloning. 
 
Transient Transfection 
 HEK 293 cell lines were transiently transfected with plasmids using Genejuice 
and according to factory specifications from Novagen. 
 
Stimulation 
 24 hours post-transfection, the cell culture media was changed and replaced with 
either: plain media; media containing TLR-specific ligands, media treated the same way 
as the media containing CVB; media containing UV-inactivated CVB; media containing 
the full concentration of CVB; and media containing a 1:100 dilution of media containing 
CVB.  CVB was prepared and purified by Dr. Neeta Shenoy.  Ligands used: TNF-α, 
PAM2 (TLR2 ligand), LPS (TLR4 ligand), Poly I:C (TLR3 ligand), CPG DNA (TLR9 
ligand). 
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Fluorescence Microscopy 
 24 hours post-stimulation, cell cultures were placed under the microscope in a 
dark room.  Fluorescent filters were used, and digital pictures were taken using the SPOT 
Advanced Program. 
 
IL-8 ELISA 
 24 hours post-stimulation, supernatants from the cell cultures were removed and 
an ELISA specific for IL-8 was performed.  ELISA’s were performed using a 1:5 sample 
dilution, following the BD Biosciences factory protocol (Franklin Lakes, New Jersey).  
Plates were prepared, and then the antibodies were added by Dr. Neeta Shenoy. 
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RESULTS 
  
 The purpose of this project was to create an in vitro system to determine whether 
CVB interacts directly with TLRs.  This project began with the goal of creating a plasmid 
which would express a fluorescent red signal upon NF-κB activation.  The commercially 
available plasmid pNF-κB-d2EGFP was not used for this because the fluorescent protein 
DsRed-Express-1 used as a reporter in this MQP aggregates less. 
 In the lab, a plasmid had just been created by Dr. Alexsandr Repik that was 
supposed to contain kappa enhancer elements and express a DsRed fluorescent signal.  
The plasmid was created by starting with pNF-κB-d2EGFP (Fig. 4) and pDsRed-Express-
1 (Fig 5).  Then two primers were created: a forward primer containing 3 NF-κB 
enhancer elements, the MCS TATA box, and the beginning of the DsRed-Express-1 
expression portion; and a reverse primer containing the end of the DsRed-Express-1 
expression portion.  Using PCR, pDsRed-Express-1 as the backbone, and the primers, a 
PCR product containing the MCS TATA box, 4 NF-κB enhancer elements, and the 
DsRed-Express-1 fluorescent protein was produced.  Then, using BglII and XbaI,   pNF-
κB-d2EGFP was digested and the TK promoter and d2EGFP were removed, and then 
subsequently replaced with the PCR product to form pNF-κB-DsRed-Express-1 (Fig. 6) 
with an additional 3 enhancer elements than the original GFP plasmid. 
 
 
 
 
 17
Figure 4: pNF-κB-d2EGFP                         Figure 5: pDsRed-Express-1 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Figure 6: PCR pNF-κB-DsRed-Express-1. 
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As seen in figure 6, there is no promoter for this vector.  However, the creator of 
this vector advocated that this vector should work, and the TATA BOX would serve as 
the promoter.  Therefore, the project moved forward with transient transfections in HEK 
293 cell lines that had previously been stably transfected with different TLRs.  Six weeks 
of transfections went by without a positive result (Table 1).   
It was determined that there may be a problem with this vector, so it was sent to 
the UMASS Medical School sequencing facility, and it was then determined that the 
vector did not have a promoter. 
 
 Table 1: Transfection Results with the PCR pNF-κB-DsRed-Express-1 
Experiment Result Notes 
1 No H2.14 DsRed Espressed, 
No expression in YFP 
TLR4/MD2 GFP Positive 
Contrlol Expressed in 
H2.14 
2 No Transfection Failed 
3 No NF-kB GFP expressed, 
DsRed Only expressed in 
H4.14 
4 No GFP expressed in all cell 
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lines, no DsRed expression 
5 No Used lipofectamine and 
genejuice in parallel, GFP 
expressed, no DsRed 
expressed 
6 No Freshly Prepped DsRed 
expressed in H2.14 and 
H4.14, GFP expressed in all 
cell lines 
 
 It was therefore decided to start over again with the two commercially available 
plasmids.  A new approach was devised, and it was determined that this problem could be 
solved by a simple ligation.  Both plasmids were digested with HindIII and SacI.  For 
pNF-κB-d2EGFP this causes two cuts to be made, one just downstream of the TK 
promoter, and one just upstream of the kappa enhancer elements.  These two cuts 
essentially remove the enhancer region and the promoter from pNF-κB-d2EGFP.  For 
pDsRed-Express-1, this also causes two cuts to be made, each inside of the MCS (Figure 
7).  The enhancer elements, and promoter were ligated into the MCS, and pNF-κB-
DsRed-Express-1 was created by Dr. Neeta Shenoy (Figure 8). 
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TNF-a Media LPS PAM2
   Figure 7: pDsRed-Express-1 MCS 
 
 
 
   Figure 8: pNF-κB-DsRed-Express-1 
  
 
 
 
 
 
 
 
 
 Several different clones were grown and then tested through transfection and 
stimulation with known ligands.  This was repeated many different times to determine 
which clone performed with the best results.  Figures 9, 10, and 11 show the first trial 
with the first clone, and they shows a positive result, as there is an up-regulation of 
fluorescent signal where TLR signaling should be occurring.   
  Figure 9: Transfection with DsRed N=1 in HEK 293 Cells 
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Media TNF-a LPS PAM2
Media TNF-a LPS PAM2
HEK 293
H2.14.12
       Media                 TNF-a                 LPS                   PAM2
H4.14.MD2
  Figure 10: Transfection with DsRed N=1 in H2.14.12 Cells 
  Figure 11: Transfecton with DsRed N=1 in H4.14.MD2 Cells 
 The transfection was then performed again, with the same results, however, this 
time there was a failure in the transfection in one of the wells (Figure 12). 
   Figure 12: Transfection with DsRed N=2 
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Transfection with DsRed Clone 1
HEK 293
    Media                    TNF-a                LPS                     PAM2
H2.14.12
  H4.14.MD2
Then, the same transfection was performed with a clone of DsRed, that was from a 
separate ligation (Figure 13).  This clone showed similar results, however there seemed to 
be a high amount of background expression of DsRed. 
 
   Figure 13: Transfection with DsRed Clone 1 
 
  
 
 
 
The same transfection protocol was then used to transfect these cells with clone 2 
(Figure 14).  The results with clone 2 produced a high amount of background expression 
of DsRed, however there was no specific up-regulation of signal where TLR activation 
should be occurring.   
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Transfection with DsRed Clone 2
HEK 293
    Media                    TNF-a                LPS                     PAM2
H2.14.12
  H4.14.MD2
   Figure 14: Transfection with DsRed clone 2 
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Transfection with DsRed Clone 3
 
 HEK 293
H2.14.12
  H4.14.MD2
    Media                   TNF-a              LPS                     PAM2
 
Then the same transfection protocol was performed using clone 3.  Similar results 
were obtained (Figure 15). 
 
 Figure 15: Transfection of HEK cells using Clone 3 
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Transfection with DsRed Clone 4
HEK 293
    Media                    TNF-a                LPS                     PAM2
H2.14.12
  H4.14.MD2
Then the transfection was performed with the DsRed Clone 4 (Figure 16).  This 
transfection looks as if there was something wrong with the ligation as little fluorescent 
signal was observed, even with the positive ligands. 
  Figure 16: Transfection with DsRed Clone 4 
 
  
 
 
 
Next, the same transfection was performed with the pNF-κB-d2EGFP plasmid, 
and a plasmid obtained from a Dr. Jennifer Wang called pCMV-GFP (Figure 17).  
pCMV-GFP is a green fluorescent protein-expressing plasmid with a cytalomegalovirus 
promoter.  The pCMV-GFP was used as a control to show the transfection protocol was 
working correctly.  The pNF-κB-d2EGFP plasmid was used as another control to 
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determine if the stimulation protocol was working correctly.  This data shows that the 
transfection protocol and NF-κB stimulation were working well. 
 
   Figure 17:  Transfection with GFP 
 
 
 Two more transfections were completed with DsRed (Figures 18 and 19).  All of 
these results indicate that this system expresses a fluorescent red signal upon NF-κB 
activation dependant upon TLR activation. 
 
 
 
 
Transfection with GFP Transfection Control 
HEK 293
        CMV            Media           TNF-a             LPS             PAM2 
H2.14.12
  H4.14.MD2
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   Figure 18: Transfection with DsRed N=3 
 
 
H2.14.12
DsRed Media DsRed TNF-a DsRed PAM2 DsRed LPS 
GFP Media GFP TNF-a GFP PAM2 GFP LPS 
HEK 293
DsRed Media DsRed TNF-a DsRed PAM2 DsRed LPS 
GFP Media GFP TNF-a GFP PAM2 GFP LPS 
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   Figure 19: Transfection with DsRed N=4 
 
H4.14.MD2 
DsRed Media DsRed TNF-a DsRed PAM2 DsRed LPS 
GFP Media GFP TNF-a GFP PAM2 GFP LPS 
HEK 293
DsRed Media DsRed TNF-a DsRed PAM2 DsRed LPS 
GFP Media GFP TNF-a GFP PAM2 GFP LPS 
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 Once it was determined that the cell line stably transfectd with TLR genes 
produced the most reliable system for detecting NF-κB activation,  media containing 
CVB were added into the cell flasks to determine if CVB interacts with any of the TLRs 
in the system (Figure 20) (Figure 21).  The cells stimulated with the UV-inactivated, 
H2.14.12
DsRed Media DsRed TNF-a DsRed PAM2 DsRed LPS 
GFP Media GFP TNF-a GFP PAM2 GFP LPS 
H4.14.MD2 
DsRed Media DsRed TNF-a DsRed PAM2 DsRed LPS 
GFP Media GFP TNF-a GFP PAM2 GFP LPS 
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concentrated CVB, and 1:100 dilution of CVB, showed high levels of NF-κB activation, 
and had also lifted off the bottom of the wells.  Also, in Figure 21, there was a slight 
problem with the fluorescence photography, as the DsRed expression photos were 
recorded in black and white.   
  Figure 20: Stimulation with Coxsackievirus N=1 
 
 
HEK 293
No TFX Media TNF-a LPS 
Control UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie 
H0.14
No TFX Media PAM2 LPS 
Control UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie 
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H2 14
No TFX Media PAM2 LPS 
Control UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie 
HEK TLR3
No TFX Media Poly I:C LPS 
Control UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie 
H4.14 
No TFX Media PAM2 LPS 
Control UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie 
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H4.MD2
No TFX Media PAM2 LPS 
Control UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie 
HEK YFP TLR9
No TFX Media TNF-a hCPG DNA 
Control UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie 
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  Figure 21: Stimulation with Coxsackievirus N=2 
 
 
HEK 293
Media  TNF-a LPS  
Control  UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie  
H0.14
Media  PAM2 LPS  
Control  UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie  
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H2.14
Media  PAM2 LPS  
Control  UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie  
HEK TLR3
Media  Poly I:C LPS  
Control  UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie  
H4.14
Media  PAM2 LPS  
Control  UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie  
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These data indicated that treatment of the reporter cells with Coxsackievirus 
activated NF-κB, so we next performed an experiment to determine which pathway 
activated NF-κB.  We performed an IL-8 ELISA to determine whether  IL-8 was 
produced by the cells stimulated by Coxsackievirus (Figure 22).  These results show 
normal IL-8 production by the cells stimulated with TLR ligands, and in the cells 
stimulated by Coxsackievirus there is IL-8 production similar to non-stimulated cell lines.  
H4.MD2
Media  PAM2 LPS  
Control  UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie  
 HEK YFP TLR9
Media  TNF-a hCPG DNA  
Control  UV-Inactivated Coxsackie 1:100 Coxsackie Conc. Coxsackie  
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This adds to the evidence that in this HEK in vitro system, CVB is not activating NF-κB 
through the TLR signal transduction pathway, but through an alternative pathway. 
 
 Figure 22: IL-8 ELISA’s Performed by Dr. Neeta Shenoy 
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DISCUSSION 
 
This project began with a few complications regarding the construct created by 
Dr. Alex Repik, but that is all part of the scientific process.  After steps were taken to 
determine that the construct was missing a promoter, a much simpler approach to making 
a construct was taken.  A new construct made by Dr. Neeta Shenoy was shown to have 
all of the necessary parts through restriction digest and southern blot, as well as 
sequencing, so an initiative was made with the transfection of the HEK cell line.  One of 
the important factors in choosing a clone to move forward was sufficient up-regulation of  
the DsRed signals to be obvious to the naked eye when NF-κB activation was occuring.  
This was because the original purpose of the project was to create a construct that was to 
be used to create transgenic zebra fish, and therefore the signal would have to be very 
strong and defined.   
After moving forward with the construct determined to have the best signal 
specificity and strength, transfections in HEK cell lines were completed several times to 
make sure that the signals were significant following activation by known TLR ligands.  
Once the in vitro system had shown it could express a strong DsRed signal upon NF-κB 
activation, it was time to move forward with Coxsackievirus stimulation.  However, by 
revisiting the Bonizzi and Karin (2004) paper, one must keep in mind that there are two 
pathways to NF-κB activation.  The pathway to NF-κB activation that follows the 
classical pathway, which originates with a receptor like the TLRs, and results in the 
production of specific cytokines and chemokines.  This is the one we would observe if 
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CVB interacts with the TLRs used in this in vitro system.  This in vitro system has the 
ability to determine what cytokines and chemokines are being produced by the cells by 
removing the supernatant media and performing an ELISA.  One of the specific 
chemokines that can be analyzed is IL-8.  This chemokine is usually indicative of NF-κB 
activation through the classical pathway.   
When Coxsackievirus was used to stimulate the NF-κB activation system, there 
was a high amount of NF-κB signaling in the cells where UV-inactivated virus, 1:100 
dilution of the virus, and the concentrated form of the virus had been added to the cells.  
This would normally lead to the belief that this had occurred via the classically pathway, 
however, it happened in every cell line with different TLRs stably transfected into each 
respective cell line.  This raised a few questions.  Another strange thing that happened is 
that the cells stimulated with CVB titers lifted off the bottom of the wells.  To determine 
whether this NF-κB signaling occurs from the classical pathway, or the alternative 
pathway, an IL-8 ELISA was performed to see if this chemokine was produced.  The data 
indicated no IL-8 was produced in this in vitro system by the cells stimulated with CVB 
titres.  This leads to the belief that the NF-κB signaling is occurring through an  
alternative pathway, which does not originate in the TLRs.   
The results of this MQP are a definitive conclusion about the in vivo effect of 
CVB.  This only shows what happens in this specific HEK cell line.  Also, there are many 
cytokines and chemokines that can be analyzed, not just IL-8.  While IL-8 is usually 
produced, there are also other cytokines produced.  Also, other cell lines should be 
analyzed other then HEK cells.  This virus may interact with TLRs in other types of cells, 
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and using a similar in vitro system it can be determined which TLR the virus may use to 
enter those cells.  Eventually the data will shed light on what may be happening in vivo. 
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